Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- CheckyesterdayChange DetectedAdded a new Locations section listing Florida and Ohio as study sites. The previous Florida Locations and Ohio Locations entries were removed, and the page revision updated to v3.3.3.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision label appears on the page, showing v3.3.2 instead of v3.3.1, indicating a site maintenance/update rather than modifications to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding status notice banner has been removed from the page. Core study details, eligibility criteria, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe new screenshot shows only superficial UI/layout updates with no changes to core study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.